LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Search

Privia Health Group Inc

Geschlossen

BrancheGesundheitswesen

23.77 -3.14

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

23.7

Max

24.37

Schlüsselkennzahlen

By Trading Economics

Einkommen

679K

6M

Verkäufe

19M

480M

KGV

Branchendurchschnitt

208.333

54.533

EPS

0.22

Gewinnspanne

1.259

Angestellte

1,140

EBITDA

39K

7.1M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+21.52% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

219M

3B

Vorheriger Eröffnungskurs

26.91

Vorheriger Schlusskurs

23.77

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Privia Health Group Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Mai 2025, 23:25 UTC

Heiße Aktien

Stocks to Watch: Navitas Semiconductor, Urban Outfitters, Lumen Technologies, LiveRamp

21. Mai 2025, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75 Billion -- Update

21. Mai 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefónica's Operations in Uruguay

21. Mai 2025, 21:01 UTC

Wichtige Markttreiber

Nvidia Selects Navitas Semiconductor to Work on Next-Generation 800V HVDC Architecture

21. Mai 2025, 23:51 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi to Buy Vigil Neuroscience for About $470 Million

21. Mai 2025, 23:49 UTC

Market Talk

Gold Edges Higher on Possible Investor Shift Away From Government Bonds -- Market Talk

21. Mai 2025, 23:37 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

21. Mai 2025, 23:33 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience: Iluzanebart Return to Licensor Amgen to Occur Prior to Closing of Sanofi Deal

21. Mai 2025, 23:32 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience Sees Sanofi Deal Strengthening Development Path for Oral Small Molecule TREM2 Agonist Program

21. Mai 2025, 23:32 UTC

Akquisitionen, Fusionen, Übernahmen

Vigil Neuroscience: Shareholders to Get Up to $10 a Share in Sanofi Deal >SAN.FR VIGL

21. Mai 2025, 23:32 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

James Hardie's Weak Update Spurs Questions Before AZEK Vote -- Market Talk

21. Mai 2025, 23:31 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Remaining Entity to Focus on Contract Development & Manufacturing Organization Business

21. Mai 2025, 23:30 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Spun-Off Entity Tentatively Named Samsung Episholdings

21. Mai 2025, 23:30 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics: Separated Business Entity to Focus on R&D Affiliate Samsungbioepis, New Investment

21. Mai 2025, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

Samsung Biologics to Spin off R&D Segment Into Separate Holdings Company

21. Mai 2025, 23:28 UTC

Ergebnisse

Singtel to Finance Buybacks Via Excess Capital Generated From Asset Recycling >Z74.SG

21. Mai 2025, 23:27 UTC

Ergebnisse

Singtel Sets Up S$2.0B Share-Buyback Program >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel: Net Rose Due to Exceptional Gain From Partial Divestment of Comcentre Headquarters >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel FY25 Rev S$14.15B Vs. S$14.13B >Z74.SG

21. Mai 2025, 23:26 UTC

Ergebnisse

Singtel FY25 Net S$4.02B Vs. Net S$795.0M >Z74.SG

21. Mai 2025, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi: VGL101, Vigil's Second Molecule Program, Isn't Being Acquired

21. Mai 2025, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi Sees No Effect From Vigil Deal on 2025 Outlook >SAN.FR

21. Mai 2025, 23:20 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi: Vigil Deal Enhances Early-Stage Pipeline, Includes VG-3927, Which Will Be Evaluated in Alzheimer's Disease Study

21. Mai 2025, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

Sanofi to Buy Vigil Neuroscience for $8 a Share at Closing >SAN.FR VIGL

21. Mai 2025, 21:42 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

AT&T to Buy Lumen's Mass Markets Fiber Business for $5.75B -- Update

21. Mai 2025, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefónica's Ops in Uruguay

21. Mai 2025, 21:07 UTC

Top News

NBCUniversal Bids for Major League Baseball Rights ESPN Dropped, Sources Say -- WSJ

21. Mai 2025, 21:06 UTC

Akquisitionen, Fusionen, Übernahmen

Uber Stock Is Dropping. Blame Elon Musk and Tesla. -- Barrons.com

21. Mai 2025, 20:59 UTC

Top News

Walmart to Cut 1,500 Jobs -- WSJ

21. Mai 2025, 20:52 UTC

Ergebnisse

Snowflake Stock Pops After Earnings Beat -- Barrons.com

Peer-Vergleich

Kursveränderung

Privia Health Group Inc Prognose

Kursziel

By TipRanks

21.52% Vorteil

12-Monats-Prognose

Durchschnitt 30.38 USD  21.52%

Hoch 40 USD

Tief 23 USD

Basierend auf 18 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Privia Health Group Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

18 ratings

17

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

23 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Privia Health Group Inc

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.